MDL | MFCD07849042 |
---|---|
Molecular Weight | 317.41 |
Molecular Formula | C16H19N3O2S |
SMILES | O=C(C(C=CC=C1)=C1S2)N2CN3CCN(C(C4CC4)=O)CC3 |
LOC14 is a potent Protein disulfide isomerase ( PDI ) inhibitor with EC 50 and K d values of 500 nM and 62 nM, respectively. LOC14 exhibits high stability in mouse liver microsomes and blood plasma, low intrinsic microsome clearance, and low plasma-protein binding [1] . LOC14 inhibits PDIA3 activity, decreases intramolecular disulfide bonds and subsequent oligomerization (maturation) of HA in lung epithelial cells [3] .
Kd: 62 nM (PDI) [1]
LOC14 (0.01-100 μM; 24 hours) exhibits the capacity to inhibit recombinant (r)PDIA3 at an IC50 of approximately 5 μM [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [3]
Cell Line: | MTEC cells |
Concentration: | 0.01 μM; 0.1 μM; 0.5 μM; 1 μM; 5 μM; 10 μM; 100 μM |
Incubation Time: | 24 hours |
Result: | Inhibited recombinant (r)PDIA3 activity. |
LOC14 (orally administered by gavage; 20 mg/kg; once daily; 12-28 weeks) significantly improves motor function, attenuated brain atrophy and extended survival in the N171–82Q HD mice [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Male N171–82Q HD mice [2] |
Dosage: | 20 mg/kg |
Administration: | Orally administered by gavage; 20 mg/kg; once daily; 12-28 weeks |
Result: | Improved motor function in HD mice. |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* The compound is unstable in solutions, freshly prepared is recommended.
DMSO : 50 mg/mL ( 157.52 mM ; ultrasonic and warming and heat to 60°C)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.1505 mL | 15.7525 mL | 31.5050 mL |
5 mM | 0.6301 mL | 3.1505 mL | 6.3010 mL |
10 mM | 0.3150 mL | 1.5752 mL | 3.1505 mL |